Remarkably, alteration of AKT activity might increase chemotherapeutic drug and hormonal resistance in BC cells [41] and these novel data suggest that Cd might further influence hormonal resistance leading to a more aggressive phenotype of BC by altering this specific signaling pathway. The gene discussed is AKT1; the disease is breast cancer.